CD274 and cancer: ICIs were grouped by mechanistic class (PD-1, PD-L1, CTLA-4, LAG-3), and additional variables included polypharmacy (number of unique drugs), sex, age, and cancer diagnosis (assigned using both indication keywords and manual curation of cancer-specific medications).